Blocking TRIM47-mediated HNF4α degradation suppresses hepatocellular carcinoma progression
Open Access
- 1 November 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (2) , 913-929
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82273096)
- National Natural Science Foundation of China (82430022)
- National Natural Science Foundation of China (82200678)
This publication has 55 references indexed in Scilit:
- Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4α proteinDiscover Oncology, 2024
- Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancerActa Pharmaceutica Sinica B, 2024
- Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapyActa Pharmaceutica Sinica B, 2023
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humansHepatology, 2022
- The TRIM proteins in cancer: from expression to emerging regulatory mechanismsClinical and Translational Oncology, 2021
- Sirtuin 2 Prevents Liver Steatosis and Metabolic Disorders by Deacetylation of Hepatocyte Nuclear Factor 4αHepatology, 2021
- Ubiquitin–proteasome system (UPS) as a target for anticancer treatmentArchives of Pharmacal Research, 2020
- Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4α geneHepatology, 2008
- The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface areaJournal of Computational Chemistry, 2008